Background/aim:A chronic neuroinflammation of disease with unknown cause and variable clinical development is multiple sclerosis (MS).Interleukin-23 (IL-23) is a constituent of the IL-12 cytokine family that has shown through development of T helper type 17 (Th17) cells development could play a chief role in the inflammatory autoimmune responses in multiple sclerosis (MS).Objective:A goal of studyis to assess IL-23 level in serum in Iraqi patients with multiple sclerosis (MS) in comparison with healthycontrol group.Methods:blood sampleswere taken from 45patients with multiple sclerosis and 30 healthy controls. IL-23 level in the serum wasassessed by Enzyme-Linked immunosorbent assay (ELISA).Results:: IL-23 level in the serum taken from affected persons was found to be significantly hiegher than its level in the serum of control group (P<0.05). We also observed significantlyhigher IL-23 serumlevels in females than males within patients group (P. Value=0.0349).Conclusions:Theresults show the increasinglevel ofIL-23 in patients with multiple sclerosis which confirms a role for IL-23 in MSsuggestedcould be a particularbiomarker and thecurative goalin MS therapythrough inhibiting.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.